Septerna and Novo Nordisk collaboration becomes effective after HSR clearance

Septerna, Inc.

Collaboration and License Agreement with Novo Nordisk became effective July 1, 2025.
Early termination of HSR waiting period triggered effectiveness of May 13, 2025 deal.
Summary of terms previously filed in May 14, 2025 8-K; full agreement to be filed in Q2 10-Q.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.